# Pinnacle Financial Partners, Inc.: financial statements, quarterly

PNFP · NYSE · CIK 2082866 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pnfp.md) · [Financials](/companies/pnfp/financials.md) · [Filings](/companies/pnfp/filings.md) · [Insiders](/companies/pnfp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pnfp/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Income tax | $m | [30.0](/filings/0002082866-26-000043.md) | [36.0](/filings/0002082866-26-000082.md) | [39.0](/filings/0002082866-26-000043.md) | [91.0](/filings/0002082866-26-000082.md) |
| Net income | $m | [140](/filings/0002082866-26-000043.md) | [159](/filings/0002082866-26-000082.md) | [150](/filings/0002082866-26-000043.md) | [328](/filings/0002082866-26-000082.md) |
| Diluted EPS | $ per share | [1.77](/filings/0002082866-26-000043.md) | [2.00](/filings/0002082866-26-000082.md) | [0.89](/filings/0002082866-26-000043.md) | [2.07](/filings/0002082866-26-000082.md) |
| Basic EPS | $ per share | [1.78](/filings/0002082866-26-000043.md) | [2.01](/filings/0002082866-26-000082.md) | [0.89](/filings/0002082866-26-000043.md) | [2.07](/filings/0002082866-26-000082.md) |

- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $bn | not reported | not reported | [52.6](/filings/0002082866-26-000018.md) | not reported | not reported | [57.7](/filings/0002082866-26-000082.md) | [123](/filings/0002082866-26-000043.md) | [129](/filings/0002082866-26-000082.md) |
| Total liabilities | $bn | not reported | not reported | [46.2](/filings/0002082866-26-000018.md) | not reported | not reported | [50.7](/filings/0002082866-26-000082.md) | [108](/filings/0002082866-26-000043.md) | [114](/filings/0002082866-26-000082.md) |
| Shareholders' equity | $bn | [5.5](/filings/0002082866-26-000018.md) | [6.0](/filings/0002082866-26-000018.md) | [6.4](/filings/0002082866-26-000082.md) | [6.5](/filings/0002082866-26-000082.md) | [6.6](/filings/0002082866-26-000082.md) | [7.0](/filings/0002082866-26-000082.md) | [14.6](/filings/0002082866-26-000082.md) | [14.8](/filings/0002082866-26-000082.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(22.0)](/filings/0002082866-26-000043.md) | [261 d](/filings/0002082866-26-000082.md) | [926](/filings/0002082866-26-000043.md) | [90.0 d](/filings/0002082866-26-000082.md) |
| Capital expenditure | $m | [20.0](/filings/0002082866-26-000043.md) | [11.0 d](/filings/0002082866-26-000082.md) | [15.0](/filings/0002082866-26-000043.md) | [23.0 d](/filings/0002082866-26-000082.md) |
| Dividends paid | $m | [19.0](/filings/0002082866-26-000043.md) | [19.0 d](/filings/0002082866-26-000082.md) | [75.0](/filings/0002082866-26-000043.md) | [75.0 d](/filings/0002082866-26-000082.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [77.0](/filings/0002082866-26-000043.md) | [77.3](/filings/0002082866-26-000082.md) | [151](/filings/0002082866-26-000043.md) | [151](/filings/0002082866-26-000082.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 151,112,640 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0002082866-26-000082.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.